In breast cancer cell panels, which have diverse expression levels of ACSL4, the level of GPX4 is inversely proportional to that of ACSL4 and cell viability, and is correlated with the effect of ACSL4 in the esterification of AA and AdA into phosphatidylethanolamines (PE). Here, ACSL4 is linked to breast carcinoma.